ClinOleic
(refined olive oil and refined soybean oil)
An olive oil-based lipid emulsion that is associated with fewer infections than soybean oil and may preserve immune function.1-4
Lipids are an integral part of parenteral nutrition (PN), but some lipid emulsions, such as 100% soybean oil, may modulate patient immune response and increase the risk of complications.3,5 Through 20 years of experience, ClinOleic maintains the lowest soybean oil content of any soy-containing composite lipid emulsion.6-11 ClinOleic also contains 80% olive oil, which has been associated with fewer infections and may preserve immune function.1-4
Aligned with international guidelines
ASPEN guidelines recommend to withhold or limit soybean oil-based lipid emulsions during the first week following the initiation of PN.18 Additionally, ESPEN guidelines recommend that lipids based solely on soybean oil be avoided.14 ClinOleic has the lowest soybean oil content of any soy-containing composite lipid product on the market, enabling the delivery of essential fatty acids while minimising the unwanted effects of soybean oil.6-11,15
Related Products
ADVERSE EVENT REPORTING
Adverse Events and any drug or medical device product quality complaints (including suspected defective medicines or medical device adverse incidents) should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse Events should also be reported to Baxter Healthcare Ltd, by email ([email protected]) or by phone (+44 (0)1635 206360).Drug or medical device product quality complaints relating to Baxter products can be reported directly to Baxter Healthcare Ltd by email ([email protected]) or by phone (+44 (0)1604 704603).